Physician profile
Richard K Sharp
NPI 1508817453
$856.64
in general payments reported to CMS, 2019-2025
22 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.73 · 2020: $80.63 · 2021: $33.55 · 2022: $123 · 2023: $134 · 2024: $97.24 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $264.27 | 2022-2025 | Vraylar |
| Pfizer INC. | $57.32 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.32 | 2020-2025 | |
| Shire North American Group INC | $55.60 | 2019 | |
| Amgen INC. | $43.82 | 2022-2025 | Repatha, Otezla |
| Boston Scientific Corporation | $38.98 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $38.05 | 2020-2025 | Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $31.72 | 2020 | |
| Organogenesis INC. | $30.88 | 2024 | Affinity |
| Exact Sciences Corporation | $28.53 | 2023-2025 | Cologuard Collection Kit |
| Globus Medical, INC. | $27.12 | 2025 | Senza |
| Corium, LLC | $21.00 | 2025 | Azstarys |
| Currax Pharmaceuticals LLC | $18.10 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.99 | 2025 | Spravato |
| Amarin Pharma, INC. | $17.53 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $17.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.79 | 2023 | Seglentis |
| Almatica Pharma LLC | $16.02 | 2021 | |
| Lucid Diagnostics INC. | $15.95 | 2023 | |
| Novo Nordisk INC | $15.40 | 2025 | Wegovy |
| Abbott Laboratories | $15.12 | 2022 | |
| Kaleo, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.